2.06
Precedente Chiudi:
$1.93
Aprire:
$1.92
Volume 24 ore:
337.31K
Relative Volume:
1.04
Capitalizzazione di mercato:
$240.71M
Reddito:
-
Utile/perdita netta:
$-13.73M
Rapporto P/E:
-15.85
EPS:
-0.13
Flusso di cassa netto:
$-3.92M
1 W Prestazione:
+4.57%
1M Prestazione:
+27.16%
6M Prestazione:
+151.25%
1 anno Prestazione:
+64.80%
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Nome
Tiziana Life Sciences Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta TLSA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TLSA
Tiziana Life Sciences Ltd
|
2.06 | 220.84M | 0 | -13.73M | -3.92M | -0.13 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2020-12-22 | Iniziato | B. Riley Securities | Buy |
2018-12-17 | Iniziato | Laidlaw | Buy |
Tiziana Life Sciences Ltd Borsa (TLSA) Ultime notizie
Trendlines Suggest Tiziana Life Sciences Ltd May Bottom Out SoonJuly 2025 Gainers & High Accuracy Trade Alerts - thegnnews.com
Price Reversal in Tiziana Life Sciences Ltd Traders Watch CloselyEarnings Performance Report & AI Driven Stock Reports - 선데이타임즈
We Think Tiziana Life Sciences (NASDAQ:TLSA) Can Easily Afford To Drive Business Growth - 富途牛牛
Is Tiziana Life Sciences Ltd stock bottoming outMarket Movement Recap & Risk Controlled Stock Alerts - Newser
Using economic indicators to assess Tiziana Life Sciences Ltd potentialJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
What institutional flow reveals about Tiziana Life Sciences Ltd2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Tiziana Life Sciences Ltd Inches Toward Key Resistance — Will It BreakWeekly Market Outlook & Weekly Sector Rotation Insights - 선데이타임즈
Multi factor analysis applied to Tiziana Life Sciences LtdJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser
Analyzing Tiziana Life Sciences Ltd with multi timeframe chartsPortfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Can Tiziana Life Sciences Ltd hit a new high this monthMarket Performance Summary & Real-Time Stock Entry Alerts - Newser
Why Tiziana Life Sciences Ltd stock attracts strong analyst attentionMarket Weekly Review & Reliable Volume Spike Trade Alerts - Newser
Is Tiziana Life Sciences Ltd in a bullish channel2025 Price Targets & Long-Term Growth Plans - thegnnews.com
Can Traders Expect Breakout From Tiziana Life Sciences Ltd This WeekQuarterly Profit Review & Reliable Entry Point Alerts - metal.it
Smart tools for monitoring Tiziana Life Sciences Ltd’s price actionJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser
Should you hold or exit Tiziana Life Sciences Ltd nowJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Tiziana Life Sciences Ltd stock momentum explainedWeekly Investment Report & Verified Stock Trade Ideas - Newser
Tiziana Life Sciences doses first MSA patient in new trial – ICYMI - Proactive financial news
Screener Results Flag Tiziana Life Sciences Ltd as Oversold2025 Risk Factors & Weekly Breakout Opportunity Watchlist - kangso.co.kr
Will Tiziana Life Sciences Ltd stock benefit from interest rate changesPortfolio Value Summary & High Yield Stock Recommendations - Newser
Applying sector rotation models to Tiziana Life Sciences LtdM&A Rumor & AI Driven Price Forecasts - Newser
Tiziana Life Sciences shares rise 2% premarket after dosing first patient in Phase 2a trial for MSA. - AInvest
Tiziana Life Sciences doses first patient in Phase 2a trial of Foralumab for rare disease - Proactive financial news
RSI Suggests Rebound May Be Near in Tiziana Life Sciences LtdWatch List & Precise Swing Trade Entry Alerts - newsimpact.co.kr
Tiziana Life Sciences doses first patient in Phase 2a MSA trial - Proactive financial news
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy - The Manila Times
Novel Intranasal Treatment Begins Trial for Incurable Brain Disorder Affecting 50,000 Americans - Stock Titan
What makes Tiziana Life Sciences Ltd stock price move sharplyJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
Top chart patterns to watch in Tiziana Life Sciences LtdBuy/Sell Zone Confirmation Technical Analysis - Newser
What moving averages say about Tiziana Life Sciences Ltd [Trade Analysis Report]Free Real-Time Buy Signal Notifications - Newser
Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Decreases and Increases - investchronicle.com
Has Tiziana Life Sciences Ltd formed a bullish divergenceEquity Market Return Forecast Model Update - Newser
Tiziana Life’s Phase IIa multiple system atrophy study gets FDA approval - Yahoo Finance
How to interpret RSI for Tiziana Life Sciences Ltd stockPredictable Return Plan with Entry Guidance - Newser
What high frequency data says about ENDRA Life Sciences Inc.Entry and Exit Strategy for Swing Traders - Newser
What analysts say about Tiziana Life Sciences Ltd stock outlookDaily Technical Forecast for Quick Gains - Newser
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy - Informazione.it
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive financial news
Market movers: Micron, Barrick, Tiziana Life Sciences, American Resources... - Proactive financial news
What moving averages say about Tiziana Life Sciences LtdSteady Return Plan Based on Data Analysis - Newser
Tiziana Life Sciences Phase 2a multiple system atrophy study green-lit by FDA - Proactive financial news
Tiziana to begin testing foralumab in multiple system atrophy - Seeking Alpha
Tiziana Life Sciences Ltd Azioni (TLSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):